检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘志泉[1] 陈康玉[1] 严激[1] 徐健[1] 苏浩[1] 杨冬妹 陈娟 胡凯[1] 章超惠 王齐[1] 谢翠平[1]
机构地区:[1]安徽医科大学附属省立医院心内科,安徽省心血管病研究所,合肥230001 [2]安徽医科大学附属省立医院超声心动图室
出 处:《临床心血管病杂志》2015年第10期1086-1090,共5页Journal of Clinical Cardiology
基 金:2013年安徽省科技攻关计划项目(No:1301042210);2010年安徽省卫生厅医学科研重点项目(No:2010A002)
摘 要:目的:探讨心电图QRS时限和形态对心脏再同步治疗(CRT)效果的影响。方法:入选植入CRT/D装置的患者272例,依据术前心电图QRS时限将其分为轻度延长(120-149ms)组、中度延长(150-179ms)组和重度延长(≥180ms)组,比较3组患者CRT反应情况;依据左束支阻滞(LBBB)诊断新标准,将患者分为真性LBBB组和假性LBBB组,比较两组患者CRT反应情况。结果:QRS时限中度(62.8%)、重度(54.3%)延长组CRT反应率优于轻度(49.6%)延长组;真性LBBB组CRT反应率优于假性LBBB组(64.3%︰52.9%)。多因素分析显示宽QRS波和真性LBBB与CRT反应率增加有关。结论:QRS时限中、重度延长组患者CRT反应率优于轻度延长组,而中度和重度延长组患者间CRT反应率无明显差别;真性LBBB组CRT反应率优于假性LBBB组。Objective:To evaluate the impact of QRS duration and morphology on response to cardiac resynchronization therapy(CRT).Method:A total of 272 patients received CRT/D implantation were enrolled.All patients were divided into mild prolonged(QRSd:120-149ms),moderate prolonged(QRSd:150-179ms),and severe prolonged(QRSd:≥180ms)group according to QRS duration.Furthermore,patients were divided into true LBBB and false LBBB group according to QRS morphology.A comparison was made according to different QRS duration and morphology.Result:Moderate and severe prolonged group(QRSd≥150ms)achieved better reverse remodeling and CRT response(62.8% or 54.3% vs.49.6%),but there was no significant difference between moderate and severe prolonged group(59.3% vs.60%).Moreover,compared with false LBBB group,true LBBB group had superior CRT response(64.3% vs.52.9%).In multivariable analyses,QRSd≥150ms and true LBBB were emerged as powerful predictor of CRT response.Conclusion:CRT response is better in patients with preimplant QRSd of≥150ms and or true LBBB but worse in patients with a QRSd of 120-149ms and or false LBBB.
分 类 号:R541.7[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.148.240.165